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Background: A vaccination programme targeted against human papillomavirus (HPV) types16 and 18 was
introduced in the UK in 2008, with the aim of decreasing incidence of cervical disease. Vaccine roll out to 12–13
year old girls with a catch-up programme for girls aged up to 17 years and 364 days was accompanied by a very
comprehensive public health information (PHI) campaign which described the role of HPV in the development of
cervical cancer.
Methods: A brief questionnaire, designed to assess acquisition of knowledge of HPV infection and its association to
cervical cancer, was administered to two different cohorts of male and female 1st year medical students (school
leavers: 83% in age range 17–20) at a UK university. The study was timed so that the first survey in 2008
immediately followed a summer's intensive PHI campaign and very shortly after vaccine roll-out (150 students). The
second survey was exactly one year later over which time there was a sustained PHI campaign (213 students).
Results: We addressed three research questions: knowledge about three specific details of HPV infection that could
be acquired from PHI, whether length of the PHI campaign and/or vaccination of females had any bearing on HPV
knowledge, and knowledge differences between men and women regarding HPV. No female student in the 2008
cohort had completed the three-dose vaccine schedule compared to 58.4% of female students in 2009. Overall,
participants’ knowledge regarding the sexually transmitted nature of HPV and its association with cervical cancer
was high in both year groups. However, in both years, less than 50% of students correctly identified that HPV
causes over 90% of cases of cervical cancer. Males gave fewer correct answers for these two details in 2009. In 2008
only around 50% of students recognised that the current vaccine protects against a limited subset of cervical
cancer-causing HPV sub-types, although there was a significant increase in correct response among female students
in the 2009 cohort compared to the 2008 cohort.
Conclusions: This study highlights a lack of understanding regarding the extent of protection against cervical
cancer conferred by the HPV vaccine, even among an educated population in the UK who could have a vested
interest in acquiring such knowledge. The intensive PHI campaign accompanying the first year of HPV vaccination
seemed to have little effect on knowledge over time. This is one of the first studies to assess detailed knowledge of
HPV in both males and females. There is scope for continued improvements to PHI regarding the link between HPV
infection and cervical cancer.
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Anogenital human papillomavirus (HPV) infection is the
most prevalent viral sexually transmitted infection (STI)
in the world today [1]. Infection is extremely common,
most prevalent among sexually active young adults and
usually follows a benign course. Persistent infection with
“high risk” (HR) HPV causes cervical disease that can
lead to cervical cancer [2]. HR-HPV types, of which
there are 15, cause over 99% of cervical cancers [3].
September 2008 saw the introduction of a UK nation-
wide HPV immunisation programme [4]. The vaccine is
now offered routinely in secondary school, to girls aged
12 – 13 years. A three-year “catch up” campaign, deliv-
ered in GP surgeries and dedicated vaccination centres,
has allowed older girls up to the age of 17 and 364 days
access to the vaccine. Boys are not vaccinated. In the
UK, between 2008 and 2012, the bivalent Cervarix vac-
cine [5] was used to protect against the two HR-HPV
types, HPV 16 and 18, that cause around 70% of cervical
cancers [1]. The vaccine was provided in three doses
over six months to elicit a protective immune response
in vaccinees prior to exposure to the virus [6].
Vaccine uptake in the UK has been excellent, at > 90%
for 12–13 year-old girls. However, uptake rates for the
catch-up programme are lower at less than 60% overall
[7]. Vaccination is accompanied by targeted public health
information (PHI), in the form of leaflets and/ or informa-
tion sharing sessions directed by trained school nurses.
Details of HPV infection and its association with cervical
cancer are explained: HPV is sexually transmitted, HPV
causes all cervical cancers, HPV vaccine protects against
two types of HPV. Therefore, young women who have
been vaccinated may be expected to have increased know-
ledge of HPV and its association with cervical cancer
compared to the unvaccinated population. At the launch
of the vaccination programme these routine information
sources were supplemented by an extremely intensive
media campaign as well as a specially developed Scottish
website (www.fightcervicalcancer.org.uk/) and associated
literature. The website has now been withdrawn and
replaced with information on immunisation (http://
www.immunisationscotland.org.uk/vaccines-and-diseases/
hpv.aspx). Although these efforts were largely targeted to
women, young men would also have been expected to
have some exposure to the media campaign because of its
intensity and range (cinema, television, radio, billboards,
newspaper adverts) in 2008 [8].
Correct knowledge about HPV infection and cervical
cancer could be important to inform decision making
regarding uptake of the vaccine. Prior to vaccine roll out
many studies revealed a lack of awareness of HPV (i.e.
whether respondents had heard of the virus) and a lack
of knowledge of the association between HPV and cervical
cancer in the UK and a range of other countries [9-14].Recent studies have demonstrated increased awareness of
HPV following the introduction of the vaccine [15,16].
However, fewer studies have investigated acquisition of
detailed knowledge of HPV infection. Those that have,
indicate low levels of more detailed knowledge of HPV
infection and links to cervical cancer [17-20]. Such know-
ledge appears to be greatest in those with higher education
levels [19].
This study was conducted at the University of Glasgow,
Scotland. Prospective medical students at this university
are admitted to study on the basis of interview where
depth of knowledge of current topics in medicine is
assessed. The HPV vaccine was one of the main topics for
2008 and 2009 so new medical students at the university
could be expected to acquire some knowledge of HPV.
HPV knowledge was assessed in two groups of first year
medical students, mean age range 17–20 years of age. The
timings of the surveys were specifically chosen. The first
survey was carried out in November 2008 immediately
following the roll-out of the HPV vaccine and a sum-
mer’s intensive media campaign that aimed to inform
the public about HPV and the HPV vaccine. The second
cohort was surveyed one year later when many more
females had received the vaccine and associated PHI.
The multimedia PHI campaign was sustained over this
one year period. Moreover, media interest in the death
from cervical cancer of the celebrity Jade Goody [21,22],
and increased discussion of HPV in the media, at the
start of 2009 coincided with the timing of interviews for
medical school of the 2009 student cohort.
We sought to answer three research questions. The
first question we addressed was knowledge about three
specific details of HPV infection that could be acquired
from reading of PHI leaflets accompanying the HPV
vaccination programme and from PHI in an intensive
media campaign between 2008 and 2009. The second
research question was whether vaccination of females in
the group and a year’s PHI campaign had any bearing
on HPV knowledge. In contract to policy in the rest of
the UK where screening starts at age 25, from age 20,
Scottish (and Welsh) women are offered three-yearly
cervical screening for the detection of HPV-associated
cervical disease. 73.7% of eligible women were screened
in the past three and a half years (as of March 31st,
2010), which is a rise in uptake of around 4.5 percent in
comparison to previous years [23]. Arguments for and
against screening before the age of 25 can be found
at http://www.cks.nhs.uk/cervical_screening/management/
scenario_when_to_offer_cervical_screening/. The final
research question was to find out if men and women ac-
quired similar levels of knowledge about HPV from the
same or different sources. This study is among the first to
compare knowledge of details of HPV of an educated
mixed gender cohort at a time of an extremely intensive
Table 1 Age ranges of the study populations (2008:
n=150, 2009: n=213) and vaccination status of female
respondents
Year 2008 2009
Female Male Female Male
Age group (n) (n) (n) (n)
17-20 83 43 97 80
21-25 10 3 11 14
>25 7 4 6 5
Total 100 50 114 99
Vaccination status % (n) N/A % (n) N/A
Not vaccinated 91 (91) 38.3 (43)
Had 1st injection 2 (2) 0.9 (1)
Had 1st and 2nd injections 4 (4) 0 (0)
Had all 3 injections 0 (0) 58.4 (66)
Do not wish vaccination 3 (3) 2.4 (3)
N/A=not applicable.
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A questionnaire survey was administered to first year
medical students at a UK university (University of
Glasgow). Medical students were chosen as a "best case
scenario" of HPV knowledge acquisition among young
adults because they are an educated population and may
have a greater awareness of current medical issues:
entry into medical school at Glasgow is by interview
where prospective students are questioned on know-
ledge of current topics in human health. Moreover, as
health professionals of the future, they may have high
motivation to pay attention to and acquire current PHI.
Student knowledge and opinion was assessed in 2008 in
that year’s intake of medical students i.e. immediately
following the implementation of HPV vaccine delivery
in the UK, and then one year later in the 2009 intake of
students. The same questionnaire was administered in
both years.
Survey questionnaire
An 8-item closed-ended questionnaire, with, for females,
a 3-item data gathering section to determine stage of
vaccination, intention to attend smear testing and smear
testing status, was developed from a literature review
and in consultation with a vaccine specialist at Health
Protection Scotland and NHS public health information
specialists. No studies examining detailed knowledge of
HPV in the UK were reported in the literature at the
time of this study so three questions relating to HPV
were designed to address specific points regarding HPV
knowledge discussed in leaflets delivered to vaccinees
and in other PHI. The draft questionnaire was piloted
on students in the final year honours virology classes of
both years. The questionnaire was then reviewed by
members with relevant expertise of the University of
Glasgow Ethics Committee and modified according to
feedback received. The survey was administered at the
same time of year, in November, first in 2008 and then
in 2009. This timing was chosen because it preceded
taught modules on cancer, including cervical cancer. The
questionnaire was completed in a ten minute period at
the end of a teaching session in a lecture theatre. One
of the researchers introduced the study and explained
the ethical permissions and voluntary nature of par-
ticipation. Students made aware of how anonymity
would be ensured. Although signed informed consent
was given, the consent forms were collected separately
to the questionnaires so that no questionnaire answerscould be traced back to an individual. Ethical approval
was obtained from the University of Glasgow’s Faculty
of Biomedical and Life Sciences Ethics Committee.
In 2008 the timing of the survey was chosen to be
immediately following first roll out of the vaccine
(September 2008) after a summer's intensive public health
campaign. This included television, radio, internet, media,
cinema and billboard adverts and age-directed leaflets
available in public places, community and health centres
and GP surgeries. Few females in the population were
vaccinated in 2008. In contrast, in 2009, many of the
female students had been offered the vaccine, delivered
in association with appropriate PHI. Moreover, there
was a sustained high level PHI campaign throughout
2009. In particular, during this period there was exten-
sive media coverage of the illness and death due to
cervical cancer of the celebrity Jade Goody [21,22].
The study group
In 2008 all 150 students (100%) and 213 out of 217
students in 2009 (98.2%) who attended the taught sessions
at which the questionnaires were given out responded to
the questionnaire. In 2008 the survey population consisted
of 100 female and 50 male participants while in 2009
the survey population contained 114 female and 99
male students. In both survey populations the majority
of students were between seventeen and twenty years
of age (84% in 2008; 83% in 2009) (Table 1). In 2008,
90% and in 2009, 87% of students were from the UK.
In 2008, 91% of the female students had not been vac-
cinated and no student had received all three vaccine
doses. In contrast, in 2009 58.4% of female students
had received three vaccine doses (Table 1). All students
who filled in the questionnaire did so completely except
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uptake of smear testing.
Data collation and analysis
Data were input into Microsoft Excel 11.5. Exact bino-
mial, Randomisation and Chi-Squared tests were used to
compare between group data. Differences were consid-
ered significant if p< 0.05. Analyses focused on questions
pertaining to knowledge of HPV and the HPV vaccine.
Results
Knowledge of details of HPV and its association with
cervical cancer
In 2008, 97.3% of the class marked as true the statement
"HPV is sexually transmitted between males and fe-
males" (Table 2). Only four students did not consider
that HPV is sexually transmitted between males and
females. However, in 2009, 10% of students did not
consider that HPV was sexually transmitted indicating
a decrease in knowledge acquisition, especially in the
male population, in the second group of students. The
medical students were asked to estimate what percent-
age of cervical cancers is due to HPV. Less than half
of all males and females in both survey populations
answered correctly. There was some difference in the
proportion of correct answers given by males in 2009
compared to 2008 (Table 2). When asked the question
"There are at least 15 different types of HPV that can
cause cervical cancer. How many of these types do
you think the vaccine protects against?" the majority
of female students in 2008 and 2009 answered correctly
that the vaccine protects against less that 5 HPV types.
There was a statistically significant positive difference inTable 2 Frequency of responses to questions in the questionn
cervical cancer
Q1: HPV is sexually transmitted between males and females:
True
False




Q3: There are at least 15 types of HPV that can cause cancer. How many of t




*= p-value <0.05: significant difference between 2008 and 2009 between the samethe response of females to this question over time (73%
answered correctly in 2009 compared to 50% of females
in 2008) (Table 2). Male responses in both years were
very similar to the 2008 female responses and showed
no statistical difference comparing responses in 2008
with 2009.
Assessing potential impact of the vaccine on uptake of
cervical smear testing
In 2008, 94% and in 2009, 87.3% of the students assessed
the cervical screening programme as “very important”.
In Scotland, women are invited for their first smear test
at age 20. Some of the female students in the survey
populations had already attended for testing: in 2008,
16.0% (n=16) of students (97% of those eligible for
screening (i.e. ≥20 years of age)) had been for a smear
test while in 2009, 13.3% (n=15) (68% of those eligible
for screening) had been tested. In both years the major-
ity of women answered positively when asked if they
would go for a smear test when invited. Importantly, in
2009, 94% of females who had been fully vaccinated said
they would attend for a smear test when invited.
Exposure to public health information on the HPV vaccine
The impact of the HPV vaccine campaign was also
examined (Table 3). Most students, male and female,
in both years claimed to have been exposed to PHI on the
HPV vaccine, reporting television advertising and word
of mouth as the main source in the 2008 survey. The
2009 survey included more options due to an increased
range of PHI resources available since the start of the
vaccination programme and most students reported
having seen these. However, in this second year, a muchaire in 2008 and 2009: Students' knowledge of HPV and
2008 2009
Female Male Female Male
% (n) % (n) % (n) % (n)
96 (96) 100 (50) 92 (105) 86 (86)
4 (4) 0 8 (9) 13 (13)*
6 (6) 4 (2) 3 (3) 10 (10)*
50 (50) 50 (25) 58 (66) 54 (54)
44 (44) 46 (23) 39 (45) 35 (35)*
hese types do
50 (50) 52 (26) 73 (83)* 51 (50)
36 (36) 30 (15) 24 (27)* 39 (39)
14 (14) 18 (9) 3 (4)* 10 (10)
gender.
Table 3 Participants’ rating of public health information (PHI) on the HPV vaccine
Year 2008 2009
Female Male Female Male
% (n) % (n) % (n) % (n)
Q1. How would you rate the PHI on the HPV vaccine?
Poor 10 (10) 20 (10) 7 (6) 9 (9)
Not bad 64 (64) 60 (30) 46 (54) 35 (36)
Very good 25 (25) 18 (9) 43 (49) 33 (33)
Don’t know 1 (1) 2 (1) 4 (5) 22 (22)
Q2. Where have you heard/seen information on the current HPV vaccination programme? Tick all that apply.
TV advertisement 72 (72) 66 (33) 79 (90) 23 (23)
Radio advertisement 24 (24) 18 (9) 31 (35) 30 (30)
Information leaflet 34 (34) 28 (14) 55 (63) 47 (48)
Poster in a pharmacy 45 (51) 50 (50)
Internet 42 (48) 41 (41)
School/College/University 42 (42) 62 (31) 75 (85) 68 (68)
GP/Doctor 26 (26) 8 (4) 18 (21) 2 (2)
Word of mouth 71 (71) 78 (39) 63 (72) 77 (77)
I have not seen/heard anything 1 (1) 2 (1) 3 (3) 3 (3)
Other* 3 (4) 5 (5)
* reported as newspapers, clinical journals.
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information from television adverts but a greater per-
centage reported receiving information by word of
mouth. More males in this year were unable to rate PHI
on the HPV vaccine.
Discussion
Summary
Many studies in different countries in a range of socio-
economic groups have demonstrated an overall lack of
awareness of HPV and its link with cervical cancer
[9-11,16,24,25]. This study represents one of the first
reports of the knowledge of educated young people in
the UK of details about HPV infection, the HPV vac-
cine and cervical cancer, and importantly, how know-
ledge changed within the first year of introduction of
the vaccination programme. The surveys were care-
fully timed to question the students when they would
have been maximally exposed to PHI and media infor-
mation on HPV and the HPV vaccine. Moreover, the
students may have had more motivation to pay attention
to details in the PHI than most other young people of this
age group because their successful entry to medical school
could depend on their displaying clear knowledge and
understanding of facts on HPV at interview. There are
few studies comparing detailed knowledge of HPV in
males and females. The young male population could
have a role in encouraging their female peers to bevaccinated so both genders were questioned in each
year’s cohort. The study included unvaccinated women
and women who were in the age group between being
offered the vaccine and being called for cervical screening.
The vast majority (99%) of the students, male and female,
questioned in each year indicated that they had seen
or heard information on the HPV vaccine indicating
some efficacy of PHI. The questionnaire assumed that
the students would have some knowledge of HPV and
cervical cancer and indeed it was clear that the level
of knowledge of this educated population was probably
greater than that of the general population [10] as re-
cently suggested [26].
Knowledge about specific details of HPV infection
The UK PHI leaflets accompanying HPV vaccination note
the sexually transmitted nature of HPV. Surprisingly, al-
though most students seemed to appreciate this fact,
in agreement with another study [27], the 2009 survey
showed a small decrease in the percentage of students
who understood that HPV was sexually transmitted.
This was despite a significant step-up in the PHI cam-
paign surrounding HPV and its link with cervical cancer
from the summer of 2008 through to autumn 2009 and
the media coverage early in 2009 of the death from cer-
vical cancer of the young celebrity Jade Goody [21,22].
However, the level of knowledge of the sexually-
transmitted nature of HPV in our cohorts was much
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of school students in Germany where less than 50%
understood that HPV was a sexually transmitted infection
[28]. It is becoming increasingly clear from similar surveys
in a number of countries that even among educated young
people there is a lack of understanding of the sexually
transmitted nature of HPV infection [18,19,29-31].
PHI leaflets clearly state that the vaccine protects
against 70% of cases of cervical cancer. However, it is
not made clear that the remaining 30% of cases are
caused by other HR-HPV types. Consequently, anecdotal
evidence suggests that the public may believe it is pos-
sible to develop cervical cancer without being infected
with HPV [16,32,33]. Students were asked to guess what
percentage of cervical cancers was caused by HPV. Only
around half of men and women in 2008 understood that
HPV caused between 80 and 100% of cervical cancers.
There was a decrease in understanding this fact between
the 2008 and 2009 surveys and a greater percentage of
men responded incorrectly in 2009.Relationship between vaccination and HPV knowledge
The vaccine PHI intended to inform the public that
the vaccine protected against two types of HPV. How-
ever, in 2008 around half the survey population did
not appear to appreciate this fact. Male understanding
did not increase by 2009 but females gave a larger number
of correct responses in that year. This could be due to the
increased percentage of vaccinated female students in
2009 that correlated with an increased number who
claimed to have seen or heard HPV information in
formal education, as expected due to the PHI delivered to
vaccinees. However, as noted above, a lower percent-
age of the 2009 cohort of women realised that HPV
caused most cervical cancers. Therefore our evidence
is equivocal that PHI delivered with the vaccine im-
proved HPV knowledge.Acquiring knowledge: gender differences in HPV
knowledge
Although there was some evidence of gender differences
in HPV knowledge, especially in the 2009 cohort, gender
did not have a significant difference on the sources of in-
formation on HPV. However, a much higher percent-
age of male students reported receiving information
from word of mouth and more males in 2009 com-
pared to 2008 were unable to rate PHI on the HPV vac-
cine. Interestingly, although the males in the study
displayed knowledge of HPV association with cervical
cancer, the majority answered ‘no’ to a question in-
cluded in the survey “Do you think males should be
offered the vaccine?” This could indicate perception of
HPV vaccination as a female issue.Limitations of the study
The study has some limitations. Prior to administering
the questionnaire it is possible that some students had
begun to prepare for the oncology portion of their course
by reading recommended materials and had thus acquired
a greater appreciation of the subject prior to questioning.
Some homogenisation of answers could have occurred
through students comparing answers in class. The re-
stricted time period (ten minutes) for filling in the
questionnaire was designed to avoid this. In itself this
may have introduced another limitation because the short
time period may have led the students to provide rapid,
poorly considered responses.
Conclusions
Public knowledge of HPV, cervical cancer and vaccination
is central to ensuring good vaccination coverage in the
female population and success of future HPV testing
strategies that will reduce the burden of disease. This
survey indicates that PHI has been somewhat successful
in delivering key elements of HPV knowledge for both
genders in the young educated population studied, but
that there are still important knowledge gaps especially
in males. Continued efforts in pressing home the main
messages regarding HPV, the HPV vaccine, and cervical
screening are required.
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